Overview
PureTech is a clinical stage biotechnology company discovering, developing and commercializing highly differentiated medicines for devastating diseases including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders, and inflammatory and immunological diseases, among others.
For Investor Relations inquiries, please contact PureTech's Investor Relations team at: ir@puretechhealth.com.
For more information, please use the links to the right.
Share Price
Corporate Presentation
Half Year Report 2019
SOLICITORS
DLA Piper UK LLP
3 Noble Street
London EC2V 7EE
United Kingdom
TEL: +44 870 011 1111
INDEPENDENT AUDITOR
KPMG LLP
15 Canada Square
London E14 5GL
United Kingdom
TEL: +44 207 311 1000
MEDIA / PR
FTI Consulting, Inc.
200 Aldersgate
Aldersgate Street
London EC1A 4HD
United Kingdom
TEL: +44 203 727 1000
Computershare Investor Services PLC
The Pavilions, Bridgwater Road
Bristol BS99 6ZZ
United Kingdom
Telephone UK: 0800 408 0094
Telephone Overseas: +44 870 889 3159
Email: web.queries@computershare.co.uk
PETER WELFORD
Jefferies International Limited
68 Upper Thames Street
London EC4V 3BJ
United Kingdom
TEL: +44 (0)20 7029 8000
AMY WALKER
Peel Hunt LLP
Moor House
120 London Wall
London EC2Y 5ET
United Kingdom
TEL: +44 (0)20 7418 8900
GRAHAM DOYLE
Liberum
Ropemaker Place
25 Ropemaker Street
London EC2Y 9LY
United Kingdom
TEL: +44 (0)20 3100 2096